세계의 의약품 첨가제 시장 : 용도별, 제형별, 기능성별, 제품별, 지역별, 경쟁 구도 - 분석 및 예측(2024-2033년)

Global Pharmaceutical Excipients Market: Focus on Application, Formulation, Functionality, Product, Region, and Competitive Landscape - Analysis and Forecast, 2024- 2033

US $ 2,475 ￦ 3,468,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,825 ￦ 5,360,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 의약품 첨가제 시장 규모는 의약품 제제에 대한 수요 증가와 약물 전달 시스템에 대한 관심 증가로 인해 강력한 성장세를 보이고 있습니다.

부형제는 활성 제약 성분(API)의 안정성, 생체 이용률 및 전반적인 효능을 향상시켜 의약품 개발에 중요한 역할을 합니다. 부형제 시장은 제약 산업의 성장, 약물 전달 기술의 발전, 만성 질환의 유행과 같은 요인에 의해 주도되고 있습니다.

주요 시장 동향으로는 방출 제어형 및 개선된 방출 전달 시스템 등 특수한 제형에 새로운 부형제를 채택하는 것을 들 수 있습니다. 또한, 엄격한 규제 요건과 제품 품질에 대한 중요성이 제약 부형제 시장 경쟁 구도를 형성하고 있습니다. 부형제 제조업체들은 연구개발에 투자하여 제약업계의 진화하는 수요를 충족하고 규제 기준을 충족하는 부형제를 혁신하고 도입하고 있습니다.

지역별로 보면, 의약품 제조 능력의 확대와 헬스케어 투자 증가로 인해 신흥 경제권에서 시장이 크게 성장하고 있습니다. 제약 첨가제 시장이 지속적으로 확대됨에 따라 이해관계자들은 역동적으로 진화하는 이 산업에서 경쟁 우위를 확보하기 위해 제휴, 인수, 제품 개발에 전략적으로 집중하고 있습니다.

이 보고서는 세계의 의약품 첨가제 시장에 대해 조사했으며, 시장 개요와 함께 용도별/제형별,/ 기능성별/제품별/지역별 동향, 시장 진출기업 프로파일 등을 전해드립니다.

목차

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망 개요
• 연구개발 리뷰
• 규제 상황
• 주요 세계 이벤트의 영향 분석- COVID-19
• 시장 역학 개요

제2장 용도

• 용도 세분화
• 용도 개요
• 세계의 의약품 첨가제 시장(용도별)
• 세계의 의약품 첨가제 시장(제제별)
• 세계의 의약품 첨가제 시장(기능별)

제3장 제품

• 제품 세분화
• 제품 개요
• 세계의 의약품 첨가제 시장(제품별)
• 세계의 의약품 첨가제 시장(제품별)

제4장 지역

• 지역별 개요
• 성장 촉진요인과 억제요인
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

제5장 시장-경쟁 벤치마킹과 기업 개요

• 향후의 유력 기업
• 지리적 평가
  • International Flavors & Fragrances Inc.
  • Ashland
  • DuPont
  • BASF SE
  • Kerry Group plc
  • Roquette Freres
  • Merck
  • Associated British Foods plc(SPI Pharma)
  • ADM
  • Wacker Chemie AG
  • Berkshire Hathaway Inc.(The Lubrizol Corporation)
  • Dow
  • BPSI Holdings LLC(Colorcon)
  • DFE Pharma
  • Croda International Plc

제6장 조사 방법

LSH

영문 목차

영문목차

“Global Pharmaceutical Excipients Market Continues to Surge, Fueled by Innovation and Demand for Advanced Drug Formulations.”

The global pharmaceutical excipients market is witnessing robust growth due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems. Excipients play a crucial role in drug development by enhancing the stability, bioavailability, and overall efficacy of active pharmaceutical ingredients (APIs). The market is driven by factors such as the growing pharmaceutical industry, advancements in drug delivery technologies, and the rising prevalence of chronic diseases.

Key market trends include the adoption of novel excipients for specialized drug formulations, such as controlled-release and modified-release delivery systems. Additionally, stringent regulatory requirements and the emphasis on product quality are shaping the competitive landscape of the pharmaceutical excipients market. Excipient manufacturers are investing in research and development to innovate and introduce excipients that comply with regulatory standards while meeting the evolving needs of the pharmaceutical industry.

Geographically, the market is experiencing significant growth in emerging economies, driven by expanding pharmaceutical manufacturing capabilities and increasing healthcare investments. With the pharmaceutical excipients market poised for continuous expansion, stakeholders are strategically focusing on partnerships, acquisitions, and product development to gain a competitive edge in this dynamic and evolving industry.

Market Segmentation:

Segmentation 1: by Application

• Taste Masking Agents
• Stabilizing Agents
• Desired Release Agents
• Solubility and Bioavailability Enhancement
• Other

Segmentation 2: by Formulation

• Oral Formulations
• Parenteral
• Local and Topical

Segmentation 3: by Functionality

• Fillers and Diluents
• Suspending and Viscosity Agents
• Coating Agents
• Colorants
• Binders
• Flavouring Agents and Sweetners
• Disintegrants
• Lubricants and Glidants
• Preservatives
• Emulsifying Agents
• Other

Segmentation 4: by Product

• Organic Chemicals
• Inoganic Chemicals
• Other

Segmentation 5: by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

Key Questions to be answered:

• What are the focus segments of the global pharmaceutical excipients market in the upcoming years?
• What is the value of revenue generated from pharmaceutical excipients market across the globe and at what rate is the demand expected to grow in the forecast period?
• Which product will be the most revenue generating in the global pharmaceutical excipients market?
• Which pharmaceutical excipients segment is estimated to hold the largest share of the market?
• Which product segment is expected to grow at the highest CAGR during the forecast period?
• Which formulation segment is expected to grow at the highest CAGR during the forecast period?
• Which excipient type segment accounted for the largest share of the pharmaceutical excipients market?
• What are the key growth factors of this market? What are the major opportunities for existing market players and new entrants in the global pharmaceutical excipients market? What are the major challenges faced by the existing players in the market?
• Who are the major players dominating in the global pharmaceutical excipients market space?
• Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the pharmaceutical excipients market for the forecast period?

Table of Contents

Executive Summary

1. Markets

• 1.1. Trends : Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- COVID- 19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.3. Global Pharmaceutical Excipients Market (by Application)
  • 2.3.1. Taste Masking Agents
  • 2.3.2. Stabilizing Agents
  • 2.3.3. Desired Release Agents
  • 2.3.4. Solubility and Bioavailability Enhancement
  • 2.3.5. Other
• 2.4. Global Pharmaceutical Excipients Market (by Formulation)
  • 2.4.1. Oral Formulations
    • 2.4.1.1. Tablets
    • 2.4.1.2. Capsules
      • 2.4.1.2.1. Hard-Gelatin Capsules
      • 2.4.1.2.2. Soft-Gelatin Capsules
    • 2.4.1.3. Liquid
    • 2.4.1.4. Other
  • 2.4.2. Parenteral
  • 2.4.3. Local and Topical
• 2.5. Global Pharmaceutical Excipients Market (by Functionality)
  • 2.5.1. Fillers and Diluents
  • 2.5.2. Suspending and Viscosity Agents
  • 2.5.3. Coating Agents
  • 2.5.4. Colorants
  • 2.5.5. Binders
  • 2.5.6. Flavouring Agents and Sweetners
  • 2.5.7. Disintegrants
  • 2.5.8. Lubricants and Glidants
  • 2.5.9. Preservatives
  • 2.5.10. Emulsifying Agents
  • 2.5.11. Other

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Pharmaceutical Excipients Market - (by Product)
  • 3.3.1. Market Overview
    • 3.3.1.1. Analyst View
• 3.4. Global Pharmaceutical Excipients Market (by Product)
  • 3.4.1. Organic Chemicals
    • 3.4.1.1. Oleochemicals
      • 3.4.1.1.1. Fatty Alcohols
      • 3.4.1.1.2. Mineral Stearates
      • 3.4.1.1.3. Glycerine
      • 3.4.1.1.4. Other
    • 3.4.1.2. Carbohydrates
      • 3.4.1.2.1. Sugars
        • 3.4.1.2.1.1. Actual Sugars
        • 3.4.1.2.1.2. Sugar Alcohols
        • 3.4.1.2.1.3. Artificial Sweetners
      • 3.4.1.2.2. Cellulose
        • 3.4.1.2.2.1. Microcrystalline Cellulose
        • 3.4.1.2.2.2. Cellulose Ethers
        • 3.4.1.2.2.3. CMC and Croscarmellose Sodium
        • 3.4.1.2.2.4. Cellulose Esters
      • 3.4.1.2.3. Starch
        • 3.4.1.2.3.1. Modified Starch
        • 3.4.1.2.3.2. Dried Starch
        • 3.4.1.2.3.3. Converted Starch
    • 3.4.1.3. Petrochemicals
      • 3.4.1.3.1. Glycols
      • 3.4.1.3.2. Povidones
      • 3.4.1.3.3. Mineral Hydrocarbons
      • 3.4.1.3.4. Acrylic Polymers
      • 3.4.1.3.5. Others
    • 3.4.1.4. Protein
    • 3.4.1.5. Other
  • 3.4.2. Inoganic Chemicals
    • 3.4.2.1. Calcium Phosphate
    • 3.4.2.2. Metal Oxides
    • 3.4.2.3. Halites
    • 3.4.2.4. Calcium Carbonate
    • 3.4.2.5. Calcium Sulphate
    • 3.4.2.6. Other
  • 3.4.3. Other

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Pharmaceutical Excipients Market By Formulation
  • 4.3.8. U.S. Pharmaceutical Excipients Market by Product
  • 4.3.9. Canada
  • 4.3.10. Canada Pharmaceutical Excipients Market By Formulation
  • 4.3.11. Canada Pharmaceutical Excipients Market by Product
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. Germany
  • 4.4.7. Germany Pharmaceutical Excipients Market By Formulation
  • 4.4.8. Germany Pharmaceutical Excipients Market by Product
  • 4.4.9. U.K.
  • 4.4.10. U.K. Pharmaceutical Excipients Market By Formulation
  • 4.4.11. U.K. Pharmaceutical Excipients Market by Product
  • 4.4.12. France
  • 4.4.13. France Pharmaceutical Excipients Market By Formulation
  • 4.4.14. France Pharmaceutical Excipients Market by Product
  • 4.4.15. Italy
  • 4.4.16. Italy Pharmaceutical Excipients Market By Formulation
  • 4.4.17. Italy Pharmaceutical Excipients Market by Product
  • 4.4.18. Spain
  • 4.4.19. Spain Pharmaceutical Excipients Market By Formulation
  • 4.4.20. Spain Pharmaceutical Excipients Market by Product
  • 4.4.21. Netherlands
  • 4.4.22. Netherlands Pharmaceutical Excipients Market By Formulation
  • 4.4.23. Netherlands Pharmaceutical Excipients Market by Product
  • 4.4.24. Rest of Europe
  • 4.4.25. Rest of Europe Pharmaceutical Excipients Market By Formulation
  • 4.4.26. Rest of Europe Pharmaceutical Excipients Market by Product
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.4. Application
  • 4.5.5. Product
  • 4.5.6. China
  • 4.5.7. China Pharmaceutical Excipients Market By Formulation
  • 4.5.8. China Pharmaceutical Excipients Market by Product
  • 4.5.9. Japan
  • 4.5.10. Japan Pharmaceutical Excipients Market By Formulation
  • 4.5.11. Japan Pharmaceutical Excipients Market by Product
  • 4.5.12. South Korea
  • 4.5.13. South Korea Pharmaceutical Excipients Market By Formulation
  • 4.5.14. South Korea Pharmaceutical Excipients Market by Product
  • 4.5.15. Australia
  • 4.5.16. Australia Pharmaceutical Excipients Market By Formulation
  • 4.5.17. Australia Pharmaceutical Excipients Market by Product
  • 4.5.18. India
  • 4.5.19. India Pharmaceutical Excipients Market By Formulation
  • 4.5.20. India Pharmaceutical Excipients Market by Product
  • 4.5.21. Rest-of-Asia-Pacific
  • 4.5.22. Rest-of-Asia-Pacific Pharmaceutical Excipients Market By Formulation
  • 4.5.23. Rest-of-Asia-Pacific Pharmaceutical Excipients Market by Product
• 4.6. Latin America
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. Brazil
  • 4.6.7. Brazil Pharmaceutical Excipients Market By Formulation
  • 4.6.8. Brazil Pharmaceutical Excipients Market by Product
  • 4.6.9. Mexico
  • 4.6.10. Mexico Pharmaceutical Excipients Market By Formulation
  • 4.6.11. Mexico Pharmaceutical Excipients Market by Product
  • 4.6.12. Rest-of-Latin America
  • 4.6.13. Rest-of-Latin America Pharmaceutical Excipients Market By Formulation
  • 4.6.14. Rest-of-Latin America Pharmaceutical Excipients Market by Product
• 4.7. Rest-of-the-World (RoW)
  • 4.7.1. Regional Overview
  • 4.7.2. Driving Factors for Market Growth
  • 4.7.3. Factors Challenging the Market
  • 4.7.4. Application
  • 4.7.5. Product

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers…..
• 5.2. Geographic Assessment
  • 5.2.1. International Flavors & Fragrances Inc.
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Ashland
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. DuPont
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. BASF SE
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. Kerry Group plc
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. Roquette Freres
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Merck
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Associated British Foods plc (SPI Pharma)
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. ADM
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. Wacker Chemie AG
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. Berkshire Hathaway Inc. (The Lubrizol Corporation)
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. Dow
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. BPSI Holdings LLC (Colorcon)
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. DFE Pharma
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. Croda International Plc
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast

관련자료